• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives

Recent Advances in the Research of 4-Methylquinoline-2-carbaldehyde (CAS: 40105-30-4)

4-Methylquinoline-2-carbaldehyde (CAS: 40105-30-4) is a quinoline derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and organic synthesis. Recent studies have explored its potential as a key intermediate in the synthesis of bioactive compounds, as well as its direct pharmacological properties. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, biological activities, and potential therapeutic applications.

One of the most notable advancements in the research of 4-Methylquinoline-2-carbaldehyde is its role in the synthesis of novel heterocyclic compounds. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its use as a precursor for the development of quinoline-based inhibitors targeting protein kinases. The study reported that derivatives synthesized from 4-Methylquinoline-2-carbaldehyde exhibited potent inhibitory activity against specific kinase isoforms, suggesting its potential in cancer therapy. The compound's aldehyde functionality was particularly emphasized for its reactivity in forming Schiff bases, which are critical for binding to kinase active sites.

In addition to its synthetic applications, 4-Methylquinoline-2-carbaldehyde has been investigated for its intrinsic biological activities. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) explored its antimicrobial properties, revealing that the compound displayed moderate activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The researchers attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity, as evidenced by electron microscopy and membrane permeability assays. These findings open new avenues for the development of antimicrobial agents based on the quinoline scaffold.

Another area of interest is the compound's potential in neurodegenerative disease research. A preprint article (2024) from a leading neuroscience lab reported that 4-Methylquinoline-2-carbaldehyde derivatives could modulate amyloid-beta aggregation, a key pathological feature of Alzheimer's disease. The study utilized molecular docking simulations and in vitro assays to demonstrate that certain derivatives could inhibit amyloid fibril formation, suggesting a possible therapeutic strategy for Alzheimer's. However, further in vivo studies are needed to validate these findings.

From a chemical perspective, recent advancements in the synthesis and characterization of 4-Methylquinoline-2-carbaldehyde have also been noteworthy. A paper in Organic & Biomolecular Chemistry (2023) described an improved synthetic route using catalytic C-H activation, which significantly enhanced the yield and purity of the compound. This methodological innovation is expected to facilitate broader applications of 4-Methylquinoline-2-carbaldehyde in both academic and industrial settings.

In conclusion, 4-Methylquinoline-2-carbaldehyde (CAS: 40105-30-4) continues to be a compound of significant interest in chemical biology and medicinal chemistry. Its dual role as a synthetic intermediate and a bioactive molecule underscores its versatility. Future research should focus on optimizing its derivatives for enhanced pharmacological properties and exploring its mechanisms of action in greater detail. The compound's potential in addressing unmet medical needs, such as antibiotic resistance and neurodegenerative diseases, makes it a promising candidate for further investigation.

• 5470-96-2(quinoline-2-carbaldehyde)
• 24160-09-6(6-Phenanthridinecarboxaldehyde)
• 94468-56-1(Quinolinecarboxaldehyde)
• 56813-20-8(6-Methyl-1H-indole-2-carbaldehyde)
• 38462-78-1(6-methylquinoline-2-carbaldehyde)
• 69164-27-8(benzoh1,6-naphthyridine-5-carbaldehyde)
• 1463-60-1(5-Methyl-1H-indole-2-carbaldehyde)
• 6760-22-1(2-Methylquinoline-4-carboxaldehyde)
• 58518-51-7(4-methyl-1H-indole-2-carbaldehyde)
• 904886-12-0(Benzo[h]quinoline-2-carbaldehyde)